TimeBlock

Natural health product licensed in Canada

Licence holder

System Biologie AG

NPN or DIN-HM

80072605

Status

Active licence

Licence date

19 September 2016

Revision date

14 March 2017

Form

Capsule

Route of administration

Orale

Application type

Non traditionnelle

If this product were sold in France

• Dose déclarée au-delà d'une limite

  Sélénium: up to 55 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).

  arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.

• Dose déclarée au-delà d'une limite

  Zinc: up to 20 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).

  arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.

• Dose déclarée au-delà d'une limite

  Vitamine B6: up to 4.2 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).

  arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.

• Dose déclarée au-delà d'une limite

  Vitamine D: up to 30 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).

  arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.

• À vérifier

  Magnésium: up to 300 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.

  limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.

• Conditions légales

  Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.

  annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.

• Conditions légales

  Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Non-medicinal ingredients

Stéarate de magnésium, Hypromellose

Recommended doses in Canada

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of vitamins and minerals to support biological functions which play a key role in the maintenance of good health. Helps to maintain healthy hair, nail, mucous membranes and/or skin Helps to maintain cognitive functions. Helps to form and maintain red blood cells. Helps to maintain normal metabolism of iron. Helps in energy metabolism and tissue formation. Helps in energy production. Helps in energy metabolism in the body. Helps in the normal function of the immune system. Helps to maintain immune function. Helps in the development and maintenance of bones and teeth. Helps to build strong bones and teeth. Helps in the absorption and use of calcium and phosphorus Helps to maintain proper muscle function. Helps to maintain proper muscle function, including the heart muscle. Source of/An electrolyte for the maintenance of good health. Helps to maintain normal electrolyte balance. Source of/An antioxidant that helps protect against oxidative stress. Helps to maintain normal function of the thyroid gland. Helps in connective tissue formation. Helps to maintain normal DNA synthesis. Helps to maintain normal acid-base metabolism. Source of/Provides antioxidants Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals Helps to support prostate health Helps to maintain/support eyesight in certain conditions (associated with sunlight damage) such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Helps to maintain and/or support cardiovascular health Source of fungal polysaccharides with immunomodulating properties.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80072605

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 14 March 2017 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2017. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.